Thomas A. Clark, Nancy E. Messonnier, Stephen C. Hadler
Childhood acellular pertussis vaccines were licensed and implemented in the US in the 1990s following an effort to improve on the safety profile of whole-cell vaccines. However, waning of immunity from acellular vaccines may be driving the recent resurgence of pertussis, raising the need to consider new prevention strategies.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados